期刊文献+

GnRH-a长效降调节和短效降调节长方案在体外受精周期中临床应用价值的比较 被引量:9

Comparison of clinical application value of GnRH-a long-acting down-regulation protocol and short-acting down-regulation long protocol in IVF/ICSI cycles
原文传递
导出
摘要 目的探讨长效和短效促性腺激素释放激素激动剂(GnRH-a)垂体降调节长方案对体外受精-胚胎移植(IVFET)结局的影响。方法回顾性分析采用黄体期GnRH-a降调解长方案进行控制性促排卵(COH)的患者235例,并根据使用GnRH-a的剂量分为两组。长效GnRH-a组120例,于黄体中期采用长效GnRH-a 1.25 mg皮下注射1次;短效GnRH-a组115例,于黄体中期采用短效GnRH-a 0.05 mg每日皮下注射1次直至注射绒膜促性腺激素(h CG)注射日。比较两组间垂体降调节效果、促排卵过程中激素水平、促性腺激素(Gn)使用剂量、时间及IVF-ET的结局。结果短效GnRH-a组与长效GnRH-a组相比垂体降调节天数较长,Gn使用天数及总剂量降低,分别为[(14.26±0.869)d和(12.64±2.024)d],[(9.85±1.98)d和(12.28±2.58)d]及[(1 808.58±602.06)u和(2 316.16±929.87)u],差异有统计学意义(P<0.01);短效GnRH-a组Gn启动日及h CG日LH水平明显高于长效GnRH-a组,分别为[(1.87±0.76)U/L和(1.53±0.92)U/L,P<0.05]及[(2.02±1.08)d和(0.993±0.766)U/L,P<0.01];两组间受精率、卵裂率、胚胎种植率、临床妊娠率及流产率差异均无统计学意义(P>0.05),长效GnRH-a组OHSS发生率高于短效GnRH-a组,差异有统计学意义(P<0.05)。结论长效GnRH-a组垂体抑制过深,在COH过程中LH水平偏低,导致Gn的用量增加,OHSS发生率增高,短效组卵泡质量高。 Objective To explore the effects of long-acting and short-acting gonadotropin-releasing hormone agonist( GnRH-a)down-regulation long protocol on outcome of in vitro fertilization and embryo transfer( IVF-ET).Methods A total of 235 patients receiving GnRH-a down-regulation long protocol during luteal phase for controlled ovarian hyperstimulation( COH) were analyzed retrospectively,then they were divided into two groups according to GnRH-a dose.A total of 120 patients in long-acting GnRH-a group were treated by intramuscular injection of long-acting GnRH-a( 1.25 mg) during mid-luteal phase for one times;115 patients in short-acting GnRH-a group were treated by intramuscular injection of short-acting GnRH-a( 0.05 mg) during mid-luteal phase until the day of human chorionic gonadotropin( h CG) injection.The effects of down-regulation,hormones levels during COH,application doses and time of gonadotrophin( Gn),and IVF-ET outcomes were compared between the two groups.Results Compared with long-acting GnRH-a group,the time of down-regulation was longer in short-acting GnRH-a group,application time and total dose were lower [( 14.26±0.869) days vs.( 12.64±2.024)days,( 9.85±1.98) days vs.( 12.28±2.58) days,( 1 808.58±602.06) U vs.( 2 316.16± 929.87) U],there were statistically significant differences( P〈0.01).The levels of LH on the day of Gn start and h CH injection in short-acting GnRH-a group were higher than those in long-acting GnRH-a group [( 1.87±0.76) U/L vs.( 1.53±0.92) U/L,( 2.02±1.08) days vs.( 0.993±0.766) U/L],there were statistically significant differences( P〈0.05,P〈0.01).There was no statistically significant difference in fertilization rate,cleavage rate,embryo implantation rate,clinical pregnancy rate,and abortion rate between the two groups( P〉 0.05).The incidence rate of ovarian hyperstimulation syndrome( OHSS) in long-acting GnRH-a group was statistically significantly higher than that in short-acting GnRH-a group( P〈0.05).Conclusion Long-acting GnRH-a suppresses pituitary strongly,which results in low level of LH during COH,high application dose of Gn,and high incidence rate of OHSS.The quality of follicles in short-acting GnRH-a group is high.
出处 《中国妇幼保健》 CAS 2016年第14期2908-2911,共4页 Maternal and Child Health Care of China
基金 上海市第一妇婴保健院院内基金支持项目(2015B12)
  • 相关文献

参考文献9

  • 1Caspi E,Ron-El R,Golan A,et al.Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins[J].Fertil Steril,1989,51(1):95-99.
  • 2Zorn JR,Boyer P,Guichard A.Never on a Sunday:programming for IVF-ET and GIFT(letter)[J].Lancet,1987,1(8529):385-386.
  • 3Tapanainen J,Hovatta O,Juntunen K,et al.Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF:a randomized comparative study[J].HumReprod,1993,8:2052-5.
  • 4Maheshwari A,Gibreel A,Siristatidis CS,et al.Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction[J].Cochrane Database Syst Rev,2011,10(8):6919-6910.
  • 5Albuquerque LE,Tso LO,Saconato H.Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles[J].Cochrane Database Syst Rev,2013,1:CD002808.
  • 6田莉,吴丹,沈浣.长、短效GnRH激动剂在控制性超排卵长方案中应用效果比较[J].中国妇产科临床杂志,2009,10(6):413-415. 被引量:22
  • 7Ren J,Sha A,Han D.Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?[J].Fertil Steril,2014,102(1):75-81.
  • 8倪丰,张莹莹,姜宏.长效促性腺激素释放激素激动剂降调时间对体外受精临床结局的影响[J].生殖医学杂志,2014,23(2):95-99. 被引量:4
  • 9Safdarianl L,Mohammadi FS,Alleyassin A,et al.Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer:a randomized double-blind clinical trial(NCT00461916)[J].Hum Reprod,2007,22(9):2449-2454.

二级参考文献13

  • 1马黔红,李尚为,黄仲英,韩字研,李培旭,邱东生,韩代文,靳松,李蕾.长效促性腺激素释放激素激动剂用于体外受精-胚胎移植中降调节后延迟卵巢启动时间的探讨[J].实用妇产科杂志,2006,22(10):603-606. 被引量:15
  • 2Stadtmauer L, Ditkoff EC, Session D, et al. High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization - embryo transfer. Fertil Steril, 1994, 61: 1058-1064.
  • 3Ma WG, Sony H, Das SK, et al. Estrogen is a critical delerminant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad SccivsA, 2003, 100: 2963-2968.
  • 4Dal Prato L, Borini A, Coticchio G, et al. Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology., a randomized study[J]. Hum Reprod, 2004,19 : 2200-2205.
  • 5Li Y, Yang D, Zhang Q. Clinical outcome o one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation[J]. J Hum Reprod Sei, 2012,5 : 14-19.
  • 6Albuquerque LE, Tso LO, Saconato H, et al. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles[CD]. Cochrane Database Syst Rev, 2013, 31 .. CD002808.
  • 7Fleming R, Chung CC, Yates follicle stimulating hormone RW, et al. Purified urinary induces differertt hormone! profiles compared with menotrophins, dependent upon th route of administration and endogenous luteinizing hormon1 activity[J]. Hum Reprod, 1996,11 1854-1858. [.
  • 8Bourgain C, Ubaldi F, Tavaniotou A, et al. Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome[J]. Fertil Steril, 2002,78 237-244.
  • 9田莉.体外受精-胚胎移植中卵巢低反应的处理对策[J].中国医刊,2007,42(12):7-9. 被引量:5
  • 10裴莉,曾品鸿,叶虹,黄国宁.两种短效曲普瑞林降调节方案诱发排卵效果比较[J].现代妇产科进展,2008,17(8):565-567. 被引量:9

共引文献24

同被引文献55

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部